Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jing,Zhang

第一单位： Department of Respiratory and Critical Care Medicine, The Center for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

作者： Jing,Zhang ^[1] ; Yuan,Zou ^[1] ; Longmin,Chen ^[2] ; Qianqian,Xu ^[1] ; Yi,Wang ^[1] ; Min,Xie ^[1] ; Xiansheng,Liu ^[3] ; Jianping,Zhao ^[1] ; Cong-Yi,Wang ^[3]

作者单位： Department of Respiratory and Critical Care Medicine, The Center for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[1] Department of Rheumatology and Immunology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[2] Department of Respiratory and Critical Care Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China. ^[3]

关键词 airway epithelial repair allergic airway inflammation asthma regulatory T cells therapeutic strategies

主题词变应原(Allergens);哮喘(Asthma);人类(Humans);免疫耐受(Immune Tolerance);炎症(Inflammation);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory)

DOI 10.3389/fimmu.2022.902318

PMID 35757774

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交